pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›COVID-19 Vaccine
drug · vaccine component
save

Coronavirus Disease 2019 (COVID-19) vaccine

Phase 3updated 6mo ago
by $SNY Sanofi🔗 ChEMBL
Phase 3
community read0 votes

🐶 often sniffed alongside

top 6
  • tagCardiology2 co-mentions · 1 sources
  • drugUndisclosed1 co-mentions · 1 sources
  • companyBarts Charity1 co-mentions · 1 sources
  • tagVaccine1 co-mentions · 1 sources
  • drugCoronavirus Disease 2019 (COVID-19) vaccine 11 co-mentions · 1 sources
  • drugundisclosed Covid-19 vaccine1 co-mentions · 1 sources

Vaccine component drug with a maximum clinical stage of Approval, with an approval for covid-19.

targets

Spike glycoprotein

all catalysts(0)

nothing on the calendar yet

Trials studying Coronavirus Disease 2019 (COVID-19) vaccine

  • phase2Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.completedn=1,164
  • phase2A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy Peoplecompletedn=1,353
  • phase1Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19active not recruitingn=20
  • —COVID-19 Vaccines International Pregnancy Exposure Registrycompletedn=1,184
  • EP1Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mixactive not recruitingn=20
  • —A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenzaactive not recruitingn=999
  • phase1A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adultsrecruitingn=225
  • phase4Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19active not recruitingn=285,000

News(10)

  • STAT+: Pharmalittle: We’re reading about a Merck AI deal, China and the pharma supply chain, and more
    Merck is entering a research collaboration with Isomorphic Labs, the AI drug designer built on a Nobel-winning technology
    stat · 1h ago
  • STAT+: NIH to move last group of its research chimps to a sanctuary
    The last chimpanzees owned by the U.S. government and still living in a laboratory will be moved to a sanctuary next year.
    stat · 18h ago
  • Pfizer leaps into ‘in vivo’ CAR-T with latest China deal
    The potentially $2.6 billion collaboration puts Pfizer into a competitive race to treat autoimmune conditions by reprogramming cells inside the body.
    biopharma_dive · 23h ago
  • STAT+: Pharmalittle: We’re reading about Overton FDA nomination being yanked, a Merck setback, and more
    The Trump administration is pulling the nomination of Heidi Overton to lead the FDA over concerns she lacked support to get confirmed by the Senate
    stat · 1d ago
  • STAT+: Pharmalittle: We’re reading about a Roche breast cancer pill, obesity drugs in children, and more
    The FDA approved a breast cancer drug from Roche, teeing up the launch of what the company has said could become its top-selling product
    stat · 2d ago
  • STAT+: Newer GLP-1 drugs to combat obesity may be the next global battleground over access to medicines, expert warns
    How obesity medications may become the next big battleground over access to medicines in lower-income countries.
    stat · 2d ago
  • STAT+: Pharmalittle: We’re reading about GLP-1 use, Covid-19 vaccine investment returns, and more
    During July and August 2025, approximately 1 in 10 U.S. adults reported taking a GLP-1 medication during the previous year
    stat · 3d ago
  • Moderna notches small profit as it prioritizes work on cancer vaccines
    International Covid-19 vaccine sales helped propel Moderna to its first profitable quarter in two years, as its return to cancer leaps forward. “I don't normally use a lot of hyperbole, but it was…
    endpoints · 13d ago
  • STAT+: Kennedy’s closing arguments for the 2026 midterms: Fraud, vaccines, and MAHA
    RFK Jr. is making his pitch ahead of a midterm election that could shape the fate of his MAHA movement.
    stat · 21d ago
  • How voters feel about trans rights and abortion access will soon be put to the test
    How do voters feel about trans students participating in school sports teams? Or abortion access? The U.S. is about to find out.
    stat · 1mo ago
view all news mentions →
brand
COVID-19 Vaccine
trade names
Vaxzevria (previously covid-19 vaccine astrazeneca)
MOA
Spike glycoprotein vaccine antigen
indication
Coronavirus Disease 2019 (COVID-19)
phase
phase_3
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 4h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?